USE OF RAD51 INHIBITORS FOR P53 GENE THERAPY

Details for Australian Patent Application No. 2001251731 (hide)

Owner PANGENE CORPORATION

Inventors REDDY, Gurucharan; ZARLING, David A.

Pub. Number AU-A-2001251731

PCT Pub. Number WO2002/058738

Priority 09/771,355 26.01.01 US

Filing date 20 March 2001

Wipo publication date 6 August 2002

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 014/47 Peptides having more than 20 amino acids

A61P 035/00 Antineoplastic agents

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

A61K 031/713 - Double-stranded nucleic acids or oligonucleotides

C12N 015/86 Mutation or genetic engineering - Viral vectors

A61K 031/7052

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2001251731

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001251732-Modular beverage dispenser

2001251730